Libra Infusions (DHA:LIBRAINFU) EV-to-EBIT: (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
20 GF Score
Price BDT611.80
View Full Analysis

What is Libra Infusions EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Libra Infusions's Enterprise Value is BDT0.00 Mil. Libra Infusions does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Libra Infusions's EV-to-EBIT at this moment.

The historical rank and industry rank for Libra Infusions's EV-to-EBIT or its related term are showing as below:

DHA:LIBRAINFU's EV-to-EBIT is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 18.87
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Libra Infusions's Enterprise Value for the quarter that ended in . 20 was BDT0.00 Mil. Libra Infusions does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Libra Infusions's Earnings Yield (Joel Greenblatt) % at this moment.

Libra Infusions  (DHA:LIBRAINFU) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Libra Infusions's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 ) =EBIT / Enterprise Value (Q: . 20 )
=/
= %

Libra Infusions EV-to-EBIT Related Terms

Libra Infusions EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Libra Infusions's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions EV-to-EBIT Chart

Libra Infusions Annual Data
Trend
EV-to-EBIT

Libra Infusions Semi-Annual Data
EV-to-EBIT

DHA:LIBRAINFU vs SECI, LENSF, ASNB: EV-to-EBIT Comparison

For the Medical Instruments & Supplies subindustry, Libra Infusions's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Libra Infusions EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Libra Infusions's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Libra Infusions's EV-to-EBIT falls into.


DHA:LIBRAINFU
20GF Score
Libra Infusions Ltd DHA:LIBRAINFU
EV-to-EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions EV-to-EBIT Calculation

Libra Infusions's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/
=

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
20GF Score

Get the complete analysis for DHA:LIBRAINFU

EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT611.80
Price